Advancing the Search for Antibodies to Treat Alzheimer’s Disease

Jul 31, 2018 | Alzheimer, Amyloid-beta

As reported in Science Daily, two studies demonstrate that not all forms of amyloid-beta protein, the protein thought to initiate Alzheimer’s disease, play an equally menacing role in the progress of the disease.  Using a new way of preparing and extracting the protein as well as a new technique to search for promising drug candidates, researchers have highlighted the importance of testing and targeting different forms of amyloid-beta.


Research/Investigative Site:

Brigham and Women’s Hospital

Lead Research/Investigator:

Dominic Walsh, PhD, a principal investigator in the Ann Romney Center.


Pin It on Pinterest